Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-21

Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on transcranial magnetic stimulation (TMS) for multiple sclerosis covering Phase 1 and Phase 2, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN